Related references
Note: Only part of the references are listed.Neuroendocrine-immune Interface: Interactions of Two Complex Systems in Health and Disease
Sandra Vela-Patino et al.
ARCHIVES OF MEDICAL RESEARCH (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages
Keiko Taniguchi-Ponciano et al.
BMC MEDICAL GENOMICS (2022)
Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features
Emre Durcan et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2022)
Clinical Biology of the Pituitary Adenoma
Shlomo Melmed et al.
ENDOCRINE REVIEWS (2022)
The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas
Sergio Andonegui-Elguera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Genetic and Epigenetic Causes of Pituitary Adenomas
Mengqi Chang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Pituitary Remodeling Throughout Life: Are Resident Stem Cells Involved?
Emma Laporte et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
Changxi Han et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma
Soudeh Ghafouri-Fard et al.
CANCERS (2021)
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
Shirin Hafezi et al.
CANCERS (2021)
LncRNA LINC00473 is involved in the progression of invasive pituitary adenoma by upregulating KMT5A via ceRNA-mediated miR-502-3p evasion
Junjun Li et al.
CELL DEATH & DISEASE (2021)
EMT-Related Markers in Serum Exosomes are Potential Diagnostic Biomarkers for Invasive Pituitary Adenomas
Kelin Chen et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
Congxin Dai et al.
FRONTIERS IN ONCOLOGY (2021)
Pangenomic Classification of Pituitary Neuroendocrine Tumors
Mario Neou et al.
CANCER CELL (2020)
Editorial: Molecular Network Study of Pituitary Adenomas
Xianquan Zhan et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Telomere length alterations and ATRX/DAXX loss in pituitary adenomas
Christopher M. Heaphy et al.
MODERN PATHOLOGY (2020)
The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness
Zihao Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Update on the Genetics of Pituitary Tumors
Sayka Barry et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
Congxin Dai et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis
Helene Lasolle et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors
Keiko Taniguchi-Ponciano et al.
SCIENTIFIC REPORTS (2020)
FGF/FGFR signaling in health and disease
Yangli Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion
Ryota Tamura et al.
ENDOCRINE PATHOLOGY (2019)
Cushing's disease due to somatic USP8 mutations: a systematic review and meta-analysis
Ingrid Quevedo Wanichi et al.
PITUITARY (2019)
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
Pedro Marques et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Cornelia Braicu et al.
CANCERS (2019)
TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas
Yohei Miyake et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Rumani Singh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Oncogene-induced senescence: a double edged sword in cancer
Xue-ling Liu et al.
ACTA PHARMACOLOGICA SINICA (2018)
The USP8 mutational status may predict long-term remission in patients with Cushing's disease
Adriana Albani et al.
CLINICAL ENDOCRINOLOGY (2018)
Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review
Frederick Yoo et al.
PITUITARY (2018)
Integration of Proteomics and Metabolomics Revealed Metabolite-Protein Networks in ACTH-Secreting Pituitary Adenoma
Jie Feng et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
mTOR promotes pituitary tumor development through activation of PTTG1
R. Chen et al.
ONCOGENE (2017)
Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease
Laura C. Hernandez-Ramirez et al.
ENDOCRINE-RELATED CANCER (2017)
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors
E. Peverelli et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Diagnosis and Treatment of Pituitary Adenomas A Review
Mark E. Molitch
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas
Garima Yagnik et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Lactate dehydrogenase A promotes the invasion and proliferation of pituitary adenoma
Jiayin An et al.
SCIENTIFIC REPORTS (2017)
Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects
Moises Mercado et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2017)
Oncogene-Induced Senescence in Pituitary Adenomas-an Immunohistochemical Study
Emilija Manojlovic-Gacic et al.
ENDOCRINE PATHOLOGY (2016)
Role of mTOR Inhibitors in Growth Hormone-Producing Pituitary Adenomas Harboring Different FGFR4 Genotypes
Shahrzad Jalali et al.
ENDOCRINOLOGY (2016)
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
Yu Mei et al.
ONCOTARGET (2016)
Tumor-Suppressor Functions of the TP53 Pathway
Brandon J. Aubrey et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Multiple Pituitary Adenomas: A Systematic Review
Renata M. Budan et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
The kinome 'at large' in cancer
Emmy D. G. Fleuren et al.
NATURE REVIEWS CANCER (2016)
Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas
Jian-Qiang Lu et al.
ENDOCRINE PATHOLOGY (2015)
Pituitary tumors contain a side population with tumor stem cell-associated characteristics
Freya Mertens et al.
ENDOCRINE-RELATED CANCER (2015)
Evidence of cellular senescence during the development of estrogen-induced pituitary tumors
Maria Eugenia Sabatino et al.
ENDOCRINE-RELATED CANCER (2015)
The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease
Luis G. Perez-Rivas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion
Cuiqi Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence
Ryusaku Matsumoto et al.
PLOS ONE (2015)
Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
Guadalupe Vargas et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Telomere length and telomerase expression in pituitary tumors
C. S. Martins et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Mutations in the deubiquitinase gene USP8 cause Cushing's disease
Martin Reincke et al.
NATURE GENETICS (2015)
Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma
Lingchao Chen et al.
CANCER LETTERS (2014)
The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy
Youwei Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
FGFR4 Polymorphic Variants Modulate Phenotypic Features of Cushing Disease
Tae Nakano-Tateno et al.
MOLECULAR ENDOCRINOLOGY (2014)
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
G. Trivellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Apoptosis: its role in pituitary development and neoplastic pituitary tissue
M. F. Guzzo et al.
PITUITARY (2014)
Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models
Carolina Cristina et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Small-molecule Bax agonists for cancer therapy
Meiguo Xin et al.
NATURE COMMUNICATIONS (2014)
Lactate Dehydrogenase A in Cancer: A Promising Target for Diagnosis and Therapy
Ping Miao et al.
IUBMB LIFE (2013)
Enhanced nestin expression and small blood vessels in human pituitary adenomas
Maria Ines Perez-Millan et al.
PITUITARY (2013)
Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence
Ruth Sanchez-Ortiga et al.
PITUITARY (2013)
Oncogene-induced senescence in pituitary adenomas and carcinomas
Krystallenia I. Alexandraki et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2012)
Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in Nonfunctioning Pituitary Adenomas: A High Throughput TMA, Immunohistochemical Study
Claudia Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Valerie Chew et al.
JOURNAL OF ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Identification of Growth Arrest and DNA-Damage-Inducible Gene β (GADD45β) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors
Katherine A. Michaelis et al.
ENDOCRINOLOGY (2011)
Signaling pathway networks mined from human pituitary adenoma proteomics data
Xianquan Zhan et al.
BMC MEDICAL GENOMICS (2010)
Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma
Isabella Lupi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pituitary senescence: The evolving role of Pttg
Vera Chesnokova et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Cooperation between Cyclin E and p27Kip1 in Pituitary Tumorigenesis
Audrey Roussel-Gervais et al.
MOLECULAR ENDOCRINOLOGY (2010)
Pituitary adenoma growth: A model for cellular senescence and cytokine action
Eduardo Arzt et al.
CELL CYCLE (2009)
Invasive Giant Prolactinoma with Loss of Therapeutic Response to Cabergoline: Expression of Angiogenic Markers
Maria Susana Mallea-Gil et al.
ENDOCRINE PATHOLOGY (2009)
Expression of p18INK4C is Down-regulated in Human Pituitary Adenomas
Md. Golam Hossain et al.
ENDOCRINE PATHOLOGY (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Genome instability: a mechanistic view of its causes and consequences
Andres Aguilera et al.
NATURE REVIEWS GENETICS (2008)
Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas
W. Saeger et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
Oncogene-induced cell senescence - Halting on the road to cancer
W. J. Mooi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Double adenomas of the pituitary: Transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation
RA Jastania et al.
ENDOCRINE PATHOLOGY (2005)
GSPα mutations in Mexican patients with acromegaly:: potential impact on long term prognosis
V Mendoza et al.
GROWTH HORMONE & IGF RESEARCH (2005)
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: Relation to tumor type, size, proliferation, and invasiveness
ZR Qian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease
DJ Simpson et al.
CLINICAL CANCER RESEARCH (2004)
Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence
A Yoshino et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas
J Itoh et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2003)
Aberrant expression of G1/S regulators is a frequent event in sporadic pituitary adenomas
DJ Simpson et al.
CARCINOGENESIS (2001)
Cyclin D and cyclin E expression in normal and adenomatous pituitary
S Jordan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Share Paper
